A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/1997
12/09/1997	US5696108 Protein kinase C inhibitors
12/09/1997	US5696076 5-lipoxygenase-activating protein II
12/09/1997	US5695955 Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
12/09/1997	US5695950 Method of screening for antimitotic compounds using the cdc25 tyrosine phosphatase
12/09/1997	US5695932 Telomerase activity assays for diagnosing pathogenic infections
12/09/1997	US5695796 Fermented milk product
12/09/1997	US5695755 Peripheralization of hematopoietic stem cells
12/09/1997	CA2058935C Pharmaceutical compositions and method for treatment using alzheimer's amyloid peptides
12/09/1997	CA1339573C Pyrimido¬4,5-d\| pyrimidine derivatives for use as bronchodilators
12/04/1997	WO1997045544A1 Antibodies to the ed-b domain of fibronectin, their construction and uses
12/04/1997	WO1997045528A2 Mammalian tolloid-like gene and protein
12/04/1997	WO1997045447A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF αvβ5 MEDIATED ANGIOGENESIS
12/04/1997	WO1997045421A1 Oxocoumarin and barbituric acid derivates, their preparation and their use as ligand inhibitors of a corticotropin-releasing factor (crf) and/or a crf-binding protein complex
12/04/1997	WO1997045407A1 Novel anandamide amidase inhibitors as analgesic agents
12/04/1997	WO1997045402A1 Phenylsulfonamide derivatives
12/04/1997	WO1997045400A1 Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers
12/04/1997	WO1997045397A1 Alkyloxyamino substituted fluorenones and their use as protein kinase c inhibitors
12/04/1997	WO1997045137A1 Methods and compositions useful for inhibition of angiogenesis
12/04/1997	WO1997045125A1 USE OF ESTROGEN TO MODIFY THE AMOUNT OF SEROTONIN TRANSPORTER OR ITS mRNA
12/04/1997	WO1997045122A1 Suppositories
12/04/1997	WO1997045121A1 Preparation for percutaneous administration
12/04/1997	WO1997045115A1 Pharmaceutical for treatment of neurological and neuropsychiatric disorders
12/04/1997	WO1997045105A1 Compositions and methods for treating or preventing diseases of body passageways
12/04/1997	WO1997040134A3 Human dnase ii
12/04/1997	WO1997039749A3 Method for the prevention and treatment of cachexia and anorexia
12/04/1997	DE19622222A1 Use of sodium=proton exchange inhibitor
12/04/1997	CA2619901A1 Pharmaceutical for treatment of neurological and neuropsychiatric disorders
12/04/1997	CA2256588A1 Methods and compositions useful for inhibition of .alpha.v.beta.5 mediated angiogenesis
12/04/1997	CA2254744A1 Oxocoumarin and barbituric acid derivates, their preparation and their use as ligand inhibitors of a corticotropin-releasing factor (crf) and/or a crf-binding protein complex
12/04/1997	CA2254339A1 Use of estrogen to modify the amount of serotonin transporter or its mrna
12/04/1997	CA2253818A1 Mammalian tolloid-like gene and protein
12/03/1997	EP0810285A2 Mutants of human Interleukin-3
12/03/1997	EP0810225A1 Process for producing paroxetine
12/03/1997	EP0810223A1 Adamantyl substituted oxindoles as pharmaceutical agents
12/03/1997	EP0810220A1 Arylacrylamide derivatives as 5HT1 agonists or antagonists
12/03/1997	EP0810206A1 Substituted 2-naphtoylguanidines, process for their preparation, their use as medicament or diagnostic agent and medicament containing them
12/03/1997	EP0809708A1 Potentiators of antibacterial agents
12/03/1997	EP0809701A1 Calcineurin regulatable adenylate cyclase
12/03/1997	EP0809699A1 New chemokines expressed in pancreas
12/03/1997	EP0809695A1 Transcription factor - e2f-5
12/03/1997	EP0809655A1 PEPTIDES AND PEPTIDOMIMETICS WITH STRUCTURAL SIMILARITY TO HUMAN p53 THAT ACTIVATE p53 FUNCTION
12/03/1997	EP0809644A1 4-substituted cephem derivatives as elastase inhibitors
12/03/1997	EP0809636A1 Substituted isoxazoles for the treatment of inflammation
12/03/1997	EP0809630A1 Indole derivatives with affinity for the cannabinoid receptor
12/03/1997	EP0809627A1 Novel borneol derivatives, methods of manufacturing them, and their pharmaceutical use
12/03/1997	EP0809517A1 Anti-transforming growth factor-beta gene therapy
12/03/1997	EP0809512A1 Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin
12/03/1997	EP0809503A1 Method of lessening the risk of vertebral fractures
12/03/1997	EP0809502A1 Method of lessening the risk of non-vertebral bone fractures
12/03/1997	EP0809499A1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine
12/03/1997	EP0809490A1 Use of lck sh2 specific compounds to treat autoimmune diseases and allograft rejection
12/03/1997	EP0809484A2 Cosmetic or pharmaceutical, particularly dermatological, composition containing a bertholletia extract
12/03/1997	EP0730651A4 Surface loop structural analogues of fibroblast growth factors
12/03/1997	EP0717733B1 Fused tricyclic heteroaromatic derivatives as dopamine receptor subtype ligands
12/03/1997	CN1166834A Benzopyram and benzo-fused compounds, their preparation and their use as leukotriene B4'(LTB4) antagonists
12/03/1997	CN1166825A Metalloproteinase inhibitors
12/03/1997	CN1166786A Retroviral protease inhibitor combinations
12/03/1997	CN1166490A Prep of novel mercaptoacetylamide derivatives
12/03/1997	CN1166329A Internal heat-reducing cooling tea
12/03/1997	CN1166316A Combination therapy to treat osteoporosis
12/03/1997	CN1036590C Process for preparation of mercaptoacetylamide derivatives
12/02/1997	US5693803 Epoxide intermediates formed by reacting amine nucleophile with activated glycidyl derivative
12/02/1997	US5693676 Using nitroglycerin to treat anal fissures or ulcers, hemorrhoids, levator spasms
12/02/1997	US5693674 Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis
12/02/1997	US5693672 3,4,5-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament containing them
12/02/1997	US5693665 Alkylated (hetero) cyclic compounds
12/02/1997	US5693657 Useful for treating hypercholesterolemia or atherosclerosis
12/02/1997	US5693655 Substituted di-indolylpiperidines for treatment of nervous system disorders
12/02/1997	US5693654 Medicaments for treating intraocular pressure
12/02/1997	US5693653 Administering an antidepressants
12/02/1997	US5693652 Benzimidazoles for ischemic heart conditions
12/02/1997	US5693649 N-substituted azaheterocyclic carboxylic acids and esters thereof
12/02/1997	US5693641 Enzyme inhibitor treating blood disorder
12/02/1997	US5693637 Bicycle derivatives, their preparation and use
12/02/1997	US5693633 Angiotensin II antagonists
12/02/1997	US5693621 Inhibiting binding of selectin to carbohydrate ligands
12/02/1997	US5693619 Method of using renin inhibiting N-(2-amino-2-oxoethyl) butanediamide derivatives
12/02/1997	US5693617 Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein
12/02/1997	US5693616 Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
12/02/1997	US5693612 Used for prophylaxis and treatment of disorders of the circulation, bones and in tumor therapy, and as antimicrobial and antiviral active compounds
12/02/1997	CA2050639C Arylalkylamines, process for preparing them and pharmaceutical compositions containing them
11/1997
11/30/1997	CA2206469A1 Preparation of substituted alkenoic acids
11/30/1997	CA2206466A1 Carbamoyl substituted heterocycles
11/30/1997	CA2205770A1 Process for producing paroxetine
11/27/1997	WO1997044468A1 HUMAN INTERLEUKIN-1j AND ANTAGONISTS THEREOF
11/27/1997	WO1997044360A1 Novel human g-protein coupled receptor
11/27/1997	WO1997044359A1 Novel human g-protein coupled receptor
11/27/1997	WO1997044354A2 Synthesis of soluble beta-sheet forming peptides
11/27/1997	WO1997044352A1 Modulating the activity of hormones or their receptors - peptides, antibodies, vaccines and uses thereof
11/27/1997	WO1997044350A1 Inhibitors of protein farnesyl transferase
11/27/1997	WO1997044337A1 Benzofuran carboxamides and their therapeutic use
11/27/1997	WO1997044329A1 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
11/27/1997	WO1997044322A1 Quinoline sulfonamides as tnf inhibitors and as pde-iv inhibitors
11/27/1997	WO1997044321A1 Antagonists of gonadotropin releasing hormone
11/27/1997	WO1997044315A1 Biphenylsulfonamide matrix metalloproteinase inhibitors
11/27/1997	WO1997044044A1 Therapeutic uses for an aminosterol compound
11/27/1997	WO1997044040A1 Hexahydro-pyrido(4,3-b)indole derivatives as antipsychotic drugs
11/27/1997	WO1997044038A1 Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
11/27/1997	WO1997044036A1 Quinoline carboxamides as tnf inhibitors and as pde-iv inhibitors
11/27/1997	WO1997043902A1 Use of gaba uptake inhibitors as anti-tussive agents

1 ... 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 1328 1329 1330 ... 1564